With Revlimid erosion coming, Bristol Myers spotlights early performance of CAR-Ts Abecma, Breyanzi kdunleavy Wed, 10/27/2021 – 11:47 More: With Revlimid erosion coming, Bristol Myers spotlights early performance of CAR-Ts Abecma, Breyanzi Source: fierce
read moreGlaxoSmithKline: Don’t count on a Shingrix rebound this year, but 2022 will bring ‘record sales’ aliu Wed, 10/27/2021 – 11:22 More: GlaxoSmithKline: Don’t count on a Shingrix rebound this year, but 2022 will bring ‘record sales’ Source: fierce
read moreEnteroBiotix completes new manufacturing facility focused on gut microbiome therapies jkeenan Wed, 10/27/2021 – 11:17 More: EnteroBiotix completes new manufacturing facility focused on gut microbiome therapies Source: fierce
read moreJohnson & Johnson inks $297M opioid deal with Texas as national deal faces holdouts esagonowsky Wed, 10/27/2021 – 11:06 More: Johnson & Johnson inks 7M opioid deal with Texas as national deal faces holdouts Source: fierce
read moreTeva’s Austedo, struggling from a pandemic slowdown, needs huge gains to meet 2021 projections esagonowsky Wed, 10/27/2021 – 09:51 More: Teva's Austedo, struggling from a pandemic slowdown, needs huge gains to meet 2021 projections Source: fierce
read morePartnership will see DNAe, Imperial College London and the University of Leicester collaborate on early detection of recurrent breast cancer More: New collaboration to develop next-gen diagnostic platform for early cancer detection Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals